The Europe Interventional Pulmonology Market would witness market growth of 6.5% CAGR during the forecast period (2023-2029).
In the interventional pulmonology market, a rapid and reliable lung cancer diagnosis is necessary. This has led to the creation of robotic bronchoscopy platforms with a hand-held controller to guide a small, flexible endoscope into the lung using computer-assisted navigation. This platform's camera enables the physician to observe a magnification of the lung, which facilitates a speedy and accurate lung cancer diagnosis.
Interventional pulmonology procedures involve using image-guided techniques, like fluoroscopy, computed tomography, and ultrasound, to diagnose and treat the spot afflicted by pain or cancer. Most frequently, interventional pulmonology procedures are used with other cancer therapies, like chemotherapy, surgery, and radiation therapy.
By offering the most cutting-edge minimally invasive techniques to identify and treat both malignant & non-malignant problems of the lungs and airways, interventional pulmonology has transformed the area of pulmonary medicine. Biopsies performed by interventional pulmonology can frequently detect the spread of mal poignancy to the lymph nodes in patients with lung cancer or other malignancies. This can assist in avoiding unneeded surgery or deciding on the best course of action.
In 2019, smoking was England's largest preventable cause of sickness and early death, killing approximately 74,600 individuals. England had an expected 506,100 smoking-related hospital admissions in 2019-2020, or about 1,400 per day. One in four hospitalized patients is a smoker. Moreover, smokers visit their general practitioner 35% more frequently than nonsmokers. The prevalence of chronic obstructive pulmonary disease (COPD) in France is anticipated to be 2,6 million, with an expected rise to 2,8 million by 2025. However, there is a lack of knowledge & awareness regarding COPD management in private healthcare settings. In light of these aspects, market participants operating in the interventional pulmonology market may encounter expansion possibilities in the region.
The Germany market dominated the Europe Interventional Pulmonology Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $390.4 million by 2029. The UK market is anticipated to grow at a CAGR of 5.6% during (2023 - 2029). Additionally, The France market would exhibit a CAGR of 7.3% during (2023 - 2029).
Based on Product, the market is segmented into Bronchoscopes, Electromagnetic Navigation Bronchoscopy System, Bronchial Thermoplasty Systems, Pleuroscopes, Respiratory Endotherapy Devices, Endobronchial Valves and Airway Stents & Pleural Catheters. Based on Indication, the market is segmented into Asthma, Lung Cancer, COPD, Tracheal & Bronchial Stenosis and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Interventional Pulmonology Market is Projected to reach USD 5.9 Billion by 2029, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Becton, Dickinson and Company, Olympus Corporation, Fujifilm Holdings Corporation, ICU Medical, Inc. (Smiths Medical), HUGER Medical Instrument Co., Ltd, Cook Medical, Inc. (Cook Group), Clarus Medical LLC and Vygon SAS.
By Product
By Indication
By End-user
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
